Panama President,  Laurentino Cortizo, announced Monday after tests that a made every six months that he has an “intermediate-risk myelodysplastic syndrome”, for which his doctors “recommended a second specialized evaluation, with molecular biology tests held in Houston, Texas after July 1”.

"Every six months the President of the Republic, Laurentino Cortizo Cohen, is subject to routine and complete blood tests. The last blood test that was carried out at the end of May showed that everything was fine, with the exception of a decrease in hemoglobin and white blood cell count," Cortizo said in a short announcement from the Presidency.

"As a result of this, his family doctor, Héctor Sánchez, recommended that the President consult with doctors José Luis Franceschi and Ricardo Díaz, recognized specialists of the national medical body. In the respective medical appointment, both doctors considered it opportune to make an aspiration and bone marrow biopsy," Cortizo added.

President Cortizo indicated that "the samples taken were sent to a specialized laboratory in the United States of America."

On Thursday, June 16, the President and the First Lady, Yazmín Colón de Cortizo, met with doctors Franceschi and Díaz, who informed them that the diagnosis given is an intermediate-risk myelodysplastic syndrome.

In this sense, doctors Franceschi and Díaz recommended a second specialized evaluation, with molecular biology tests, which will be carried out in Houston, Texas after July 1, when the President attends the National Assembly to render the Report. to the Nation.

Doctors Franceschi and Díaz certified that: "the physical examination of Mr. President is normal and he is in excellent general condition."

The evolution of the health condition of the President will be promptly communicated to the population, to the extent necessary reports TVN.